Analysts at William Blair Give Envision Healthcare (NYSE:EVHC) a Downgrade

Henrietta Strickland
June 13, 2018

Under the terms of the transaction, Envision Healthcare shareholders will receive only $46.00 in cash for each share of Envision Healthcare stock they own. As per Monday, January 8, the company rating was maintained by Stephens. William Blair downgraded shares of Envision Healthcare from an "outperform" rating to a "market perform" rating in a report on Monday. Arizona State Retirement System boosted its position in Envision Healthcare by 0.3% in the first quarter. Bank of Montreal Can now owns 41,752 shares of the company's stock valued at $1,442,000 after acquiring an additional 2,515 shares during the period. Finally, Verition Fund Management LLC bought a new stake in shares of Envision Healthcare during the first quarter valued at about $221,000. Aperio Group LLC lifted its stake in Envision Healthcare by 178.2% in the fourth quarter. State Treasurer State of MI now owns 38,600 shares of the company's stock valued at $2,367,000 after buying an additional 200 shares in the last quarter. Institutional investors own 35.96% of the company's stock. Envision Healthcare has a fifty-two week low of $23.77 and a fifty-two week high of $64.00.

Envision shares were adding 2.67 percent to $44.80 Monday morning after the announcement.

The companies said the share price in this deal is a 32-percent premium to the volume-weighted average price the day after the company said it would review strategic options. The firm has a market capitalization of $5.29 billion, a price-to-earnings ratio of 18.00, a PEG ratio of 0.99 and a beta of 0.46. Mizuho set a $38.00 price objective on shares of Envision Healthcare and gave the company a "hold" rating in a research note on Friday, March 2nd. The company reported $0.71 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.64 by $0.07. Envision Healthcare had a return on equity of 4.59% and a net margin of 1.41%. The firm also took WebMD Health Corp private for about US$2.8 billion.

Shares of Envision Healthcare opened at $43.64 on Friday, reports. The firm is expected to issue its next quarterly earnings report on Monday, August 6th.

Baird downgraded Envision Healthcare (NYSE:EVHC) shares to a Hold rating in analysts report issued to investors and clients today. On Wednesday, February 28 the stock rating was maintained by Cantor Fitzgerald with "Neutral". The company was maintained on Wednesday, March 7 by Robert W. Baird. The rating was maintained by Cantor Fitzgerald with "Hold" on Tuesday, April 10. Envision Healthcare now has a consensus rating of "Hold" and an average price target of $41.10. As per Wednesday, April 11, the company rating was maintained by Robert W. Baird. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company.

Envision Healthcare Corporation (NYSE:EVHC) has declined 22.24% since June 12, 2017 and is downtrending. The company operates through two segments, Physician Services and Ambulatory Services.

Other reports by Click Lancashire

Discuss This Article